1Leivo T,Leivo I,Kariniemi AL,et al.Down-regulation oftransforming growth factor-beta receptors landlI is seen in lesional but not non-lesional psoriatic epidermis.Bf J Dermatol,1998 ; 138(1):57-62.
3rrajewska M,Krajewski S,Epstein JI,et al.Immunohistochemical analysis of bc122,bax,bcl2xl,and MC121 expression in prostate cancancers.Am JPathol,1996 ; 148:1567-1576.
4Wrana JL,Attisano L,Wieser R,ET al.Mechanism of activatiOn of the TGF-β receptor.Nature,1994 ;370(6488):341-347.
5Cebtrella M,Ji CH,Casinghino S,et al,Rapid flux in transfotining growth fator-preceptor on bone cells.Biol Chem,1996;271(31):18616-18622.
6Van de Kerkhof PC,Rulo HF,Van Pelt JP,et al.EX-pression of endoglin in the transition between psoriatic uninvolved and involved skin.Acta Derm Venereol,1998 ;78(1):19-21.
8Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction[J]. J Cell Sci, 2001,114(Pt 24): 4359--4369.
9Flisiak I, Chodynicka B, Porebski P, et al. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions [J]. Cytokine, 2002, 19(3): 121-125.
10Leivo T, Leivo I, Kariniemi AL, et al. Down-regulation of transforming growth factor-beta receptors Ⅰ and Ⅱ is seen in lesional but not non-lesional psoriatic epidermis[J]. Br J Dermatol, 1998, 138(1): 57-62.
